Genome-wide association study of cognitive decline in schizophrenia.
作者信息
Hashimoto Ryota, Ikeda Masashi, Ohi Kazutaka, Yasuda Yuka, Yamamori Hidenaga, Fukumoto Motoyuki, Umeda-Yano Satomi, Dickinson Dwight, Aleksic Branko, Iwase Masao, Kazui Hiroaki, Ozaki Norio, Weinberger Daniel R, Iwata Nakao, Takeda Masatoshi
出版信息
Am J Psychiatry. 2013 Jun;170(6):683-4. doi: 10.1176/appi.ajp.2013.12091228.
Abstract
摘要
相似文献
1
Genome-wide association study of cognitive decline in schizophrenia.精神分裂症认知衰退的全基因组关联研究。
Am J Psychiatry. 2013 Jun;170(6):683-4. doi: 10.1176/appi.ajp.2013.12091228.
2
Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.全基因组支持的变异 MIR137 和严重的阴性症状预测精神分裂症认知受损亚型的成员身份。
Mol Psychiatry. 2013 Jul;18(7):774-80. doi: 10.1038/mp.2012.84. Epub 2012 Jun 26.
3
Polymorphisms in schizophrenia candidate gene UFD1L may contribute to cognitive deficits.精神分裂症候选基因 UFD1L 多态性可能导致认知缺陷。
Psychiatry Res. 2013 Aug 30;209(1):110-3. doi: 10.1016/j.psychres.2013.03.035. Epub 2013 Apr 23.
4
Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia.精神分裂症中15q12基因变异与皮质厚度及认知的关联
Arch Gen Psychiatry. 2011 Aug;68(8):781-90. doi: 10.1001/archgenpsychiatry.2011.81.
5
The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample.儿茶酚-O-甲基转移酶（COMT）基因及其与精神分裂症的潜在关联：来自大型德国病例对照和家系样本的研究结果。
Schizophr Res. 2010 Sep;122(1-3):24-30. doi: 10.1016/j.schres.2010.06.018. Epub 2010 Jul 19.
6
Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder.美国精神分裂症或双相情感障碍退伍军人认知表现的全基因组关联研究。
Am J Med Genet B Neuropsychiatr Genet. 2020 Apr;183(3):181-194. doi: 10.1002/ajmg.b.32775. Epub 2019 Dec 24.
7
Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.通路中 ZNF804A 基因的上位性与多基因分数对工作记忆表现变异性的解释
JAMA Psychiatry. 2014 Jul 1;71(7):778-785. doi: 10.1001/jamapsychiatry.2014.528.
8
Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.一氧化氮合酶1（NOS1）对精神分裂症患者和健康对照者言语智力及工作记忆的影响。
Arch Gen Psychiatry. 2009 Oct;66(10):1045-54. doi: 10.1001/archgenpsychiatry.2009.139.
9
Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients.MAGI2 基因常见变异与精神分裂症患者认知障碍风险增加相关。
PLoS One. 2012;7(5):e36836. doi: 10.1371/journal.pone.0036836. Epub 2012 May 23.
10
Less cognitive and neurological deficits in schizophrenia patients carrying risk variant in ZNF804A.携带 ZNF804A 风险变异的精神分裂症患者认知和神经缺陷较少。
Neuropsychobiology. 2012;66(3):158-66. doi: 10.1159/000339731. Epub 2012 Aug 29.
引用本文的文献
1
Temporal Effects of Disease Signature Genes and Core Mechanisms in the Hyperacute Phase of Acute Ischemic Stroke: A Bioinformatics Analysis and Experimental Validation.急性缺血性脑卒中超急性期疾病特征基因和核心机制的时间效应：生物信息学分析与实验验证
Mediators Inflamm. 2025 Jun 6;2025:6808184. doi: 10.1155/mi/6808184. eCollection 2025.
2
Inactive metallopeptidase homologs: the secret lives of pseudopeptidases.无活性金属肽酶同源物：假肽酶的隐秘生活
Front Mol Biosci. 2024 Jul 10;11:1436917. doi: 10.3389/fmolb.2024.1436917. eCollection 2024.
3
Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illness.纹状体的多巴胺能组织与皮质活动和与精神疾病相关的大脑基因表达有关。
Sci Adv. 2021 Jun 9;7(24). doi: 10.1126/sciadv.abg1512. Print 2021 Jun.
4
Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.多基因风险评分可区分精神分裂症和双相情感障碍，与精神分裂症患者和健康受试者的发病前智力相关。
Int J Neuropsychopharmacol. 2021 Jul 23;24(7):562-569. doi: 10.1093/ijnp/pyab014.
5
Facilitative Effects of Transcranial Direct Current Stimulation on Semantic Memory Examined by Text-Mining Analysis in Patients With Schizophrenia.经颅直流电刺激对精神分裂症患者语义记忆的促进作用：基于文本挖掘分析的研究
Front Neurol. 2021 Feb 11;12:583027. doi: 10.3389/fneur.2021.583027. eCollection 2021.
6
Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.可成药的神经酰胺代谢途径：实验模型与临床机遇
Adv Exp Med Biol. 2020;1274:101-135. doi: 10.1007/978-3-030-50621-6_6.
7
Expression of Carboxypeptidase X M14 Family Member 2 Accelerates the Progression of Hepatocellular Carcinoma via Regulation of the gp130/JAK2/Stat1 Pathway.羧肽酶X M14家族成员2的表达通过调节gp130/JAK2/Stat1信号通路加速肝细胞癌的进展。
Cancer Manag Res. 2020 Mar 31;12:2353-2364. doi: 10.2147/CMAR.S228984. eCollection 2020.
8
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.基质金属蛋白酶-9（MMP-9）的血浆水平与精神分裂症患者的认知表现相关。
Neuropsychopharmacol Rep. 2020 Jun;40(2):150-156. doi: 10.1002/npr2.12098. Epub 2020 Feb 5.
9
The Cytoplasmic Expression Of CLDN12 Predicts An Unfavorable Prognosis And Promotes Proliferation And Migration Of Osteosarcoma.CLDN12的细胞质表达预示着骨肉瘤预后不良，并促进骨肉瘤的增殖和迁移。
Cancer Manag Res. 2019 Nov 1;11:9339-9351. doi: 10.2147/CMAR.S229441. eCollection 2019.
10
Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma.羧肽酶X M14家族成员2的过表达预示骨肉瘤预后不良，并促进骨肉瘤的增殖和迁移。
Diagn Pathol. 2019 Oct 24;14(1):118. doi: 10.1186/s13000-019-0887-0.
本文引用的文献
1
Genome-wide association study identifies five new schizophrenia loci.全基因组关联研究确定了五个新的精神分裂症易感基因位点。
Nat Genet. 2011 Sep 18;43(10):969-76. doi: 10.1038/ng.940.
2
Stability and course of neuropsychological deficits in schizophrenia.精神分裂症神经心理缺陷的稳定性及病程
Arch Gen Psychiatry. 2001 Jan;58(1):24-32. doi: 10.1001/archpsyc.58.1.24.
3
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.精神分裂症患者的认知障碍表现为智力保留和受损。
Arch Gen Psychiatry. 2000 Sep;57(9):907-13. doi: 10.1001/archpsyc.57.9.907.
Zotero 插件